Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $96.38M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 2.13M
Average 1.15M
Returns on capital
Quanterix Corporation management
Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.
Return Metrics
ROE, ROIC & ROA over time
ROE
-36.2%
avg -29.7%
ROIC
-29.8%
avg -108.7%
ROA
-25.6%
avg -42.4%
Analysis
ROA is currently the strongest return metric at -25.6% versus its period average of -42.4%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Leadership
Who runs the company?
Review the executive team, tenure, compensation, and ownership.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|
Everett V. Cunningham | President, Chief Executive Officer & Director | USD 1.23M | 60 | — | — |
Jason Faessler | Chief Financial Officer & Treasurer | USD 787.23K | — | — | — |
William Donnelly | Executive Chair | USD 258.64K | 64 | — | — |
David R. Walt | Co-Founder & Chairman of Scientific Advisory Board | USD 50.94K | 73 | 1.87M | 3.98% |
Michael Miller | Chief Technology & Products Officer | — | 62 | — | — |
Joshua Young | Head of Investor Relations | — | — | — | — |
Anthony Catalano | Chief Operating Officer | — | — | — | — |
Daniel S. Char | Chief Legal Officer & Corporate Secretary | — | 65 | — | — |
Naren Bhat | Chief Strategy Officer | — | — | — | — |
Erica Bell | Chief People Officer | — | 53 | — | — |
Compensation is shown in the reported currency; data updated Nov 7, 2026.
Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Jan 2, 2026.
Insider trading
Are insiders buying or selling?
Follow recent insider purchases and sales reported on Form 4.
Insider Trading
SEC Form 4 transactions — last 12 months
Buys
3
$296,049.10
Sells
0
$0.00
Net Transaction Value
+$296,049.10
Net buying
Most Active
DONNELLY WILLIAM P
2 transactions
Transactions sorted by date, descending.
| Type | |||
|---|---|---|---|
| Aug 13, 26Aug 13, 2026 | DONNELLY WILLIAM P Indirect | Buy | $211.7K$211,677.85 |
| Aug 12, 26Aug 12, 2026 | DONNELLY WILLIAM P Indirect | Buy | $74.7K$74,676.25 |
| May 12, 26May 12, 2026 | Meadows Benjamin Direct | Buy | $9.7K$9,695.00 |
Summary
Insiders reported 3 buys worth $296,049.10 and 0 sells worth $0.00 over the last 12 months. That adds up to net buying of $296,049.10. DONNELLY WILLIAM P was the most active insider with 2 transactions.
Growth analysis
Is management growing the business?
Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | +9.5% | +10.0% (5yr)2 analysts |
| Net Income | N/A | N/A | N/A | N/A2 analysts |
| EBIT | N/A | N/A | N/A | N/A2 analysts |
Analysis
Recent growth has been strongest in Revenue at +9.5% over three years. Forward estimates point to Revenue at +10.0% (5yr), giving you a quick check on whether expectations are accelerating or cooling.
Competitors
Who does Quanterix Corporation compete with?
Open similar companies to compare how their management teams allocate capital.
Competitors
Peer companies in the same sector
Questions
Management questions
Common questions about QTRX's management, answered from reported figures.
Who manages QTRX?
Quanterix Corporation (QTRX) lists 10 active executives. The top listed executive is Michael Miller, Chief Technology & Products Officer.
Are QTRX insiders buying or selling?
Recent insider activity shows net buying of $351,503.42.
Continue the stock analysis
Jump to another research area for this company.